全文获取类型
收费全文 | 5106篇 |
免费 | 357篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 160篇 |
妇产科学 | 126篇 |
基础医学 | 914篇 |
口腔科学 | 37篇 |
临床医学 | 412篇 |
内科学 | 982篇 |
皮肤病学 | 102篇 |
神经病学 | 612篇 |
特种医学 | 166篇 |
外科学 | 523篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 440篇 |
眼科学 | 146篇 |
药学 | 315篇 |
中国医学 | 10篇 |
肿瘤学 | 425篇 |
出版年
2023年 | 33篇 |
2022年 | 67篇 |
2021年 | 110篇 |
2020年 | 85篇 |
2019年 | 90篇 |
2018年 | 113篇 |
2017年 | 81篇 |
2016年 | 119篇 |
2015年 | 120篇 |
2014年 | 157篇 |
2013年 | 188篇 |
2012年 | 304篇 |
2011年 | 324篇 |
2010年 | 231篇 |
2009年 | 194篇 |
2008年 | 302篇 |
2007年 | 282篇 |
2006年 | 342篇 |
2005年 | 284篇 |
2004年 | 262篇 |
2003年 | 233篇 |
2002年 | 223篇 |
2001年 | 90篇 |
2000年 | 84篇 |
1999年 | 85篇 |
1998年 | 60篇 |
1997年 | 64篇 |
1996年 | 35篇 |
1995年 | 45篇 |
1994年 | 31篇 |
1993年 | 30篇 |
1992年 | 50篇 |
1991年 | 53篇 |
1990年 | 53篇 |
1989年 | 71篇 |
1988年 | 40篇 |
1987年 | 46篇 |
1986年 | 38篇 |
1985年 | 33篇 |
1984年 | 49篇 |
1983年 | 24篇 |
1982年 | 18篇 |
1980年 | 24篇 |
1979年 | 34篇 |
1978年 | 18篇 |
1977年 | 23篇 |
1975年 | 20篇 |
1974年 | 20篇 |
1973年 | 17篇 |
1969年 | 19篇 |
排序方式: 共有5473条查询结果,搜索用时 15 毫秒
61.
There are conflicting reports about estrogen modulating the activity of nigrostriatal dopaminergic neurons. Furthermore, modulation may be influenced by progesterone levels. Therefore, the clinical effects of sex steroids on parkinsonian symptoms in postmenopausal women with Parkinson's disease (PD) were analyzed in the present study. Patients (n = 12) were under the age of 80, able to perform the motor function tests, and showed no contraindications for estrogen suppletion. Motor function was assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) and a patient interview on subjective changes. In a placebo-controlled, randomized, double-blind trial lasting 8 weeks, no significant dopaminergic effect of estradiol (E2) could be demonstrated, whereas in an open trial phase lasting 2 weeks, progesterone seemed to have an antidopaminergic effect. Several mechanisms are discussed that can account for the fact that we found no effect of E2 on motor functioning in our patients with PD. 相似文献
62.
3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum
Vis JC Verbeek MM De Waal RM Ten Donkelaar HJ Kremer HP 《Neuropathology and applied neurobiology》1999,25(6):513-521
Systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP) to rats results in selective striatal lesions and serves as an experimental model of Huntington's disease (HD). However, the effects of the 3-NP treatment are unpredictable and result in lesions of variable severity. The present study was aimed at further characterizing the variability of the striatal lesions induced by systemic administration of 3-NP using osmotic pumps. Hematoxylin-eosin (HE) and Nissl stains as well as immunohistochemical labelling of astrocytes and striatal neurones were performed to analyse the neurotoxic effects of 3-NP. In general, chronic systemic administration of 3-NP resulted in obvious bilateral striatal lesions, which ranged from mild to severe, together with a subtle, but detectable behavioural lesion. Severe type lesions showed marked neuronal loss and an increased expression of glial fibrillary acidic protein (GFAP) in astrocytes surrounding the lesion area, whereas in the core of the lesion GFAP-immunoreactivity was absent. The mild type lesion was characterized by a substantial loss of striatal neurones and an increased expression of GFAP-positive astrocytes throughout the lesion. In a number of 3-NP-treated animals, neither type of lesion was observed, although these animals demonstrated behavioural changes in the paw test compared to controls. In the striatum of these tested 3-NP-treated animals, compromised rk' neurones were detected, suggestive of subtle and early 3-NP-induced neuronal injury. Similar dark neurones were also detected in mild and severe lesions and were immunocytochemically characterized as gamma-aminobutyric acid (GABA) and substance P containing spiny neurones, which belong to the neuronal population that is affected in early HD. These results indicate that systemic administration of 3-NP to rats may result in a spectrum of striatal pathology of which the morphology of the mild type lesion resembles the characteristic HD neuropathology most closely. 相似文献
63.
64.
Thybusch-Bernhardt A Schmidt C Küchler T Schmid A Henne-Bruns D Kremer B 《World journal of surgery》1999,23(5):503-508
Quality of life (QOL) in patients with gastric cancer who underwent total gastrectomy has so far not been studied using the
EORTC QLQ-C30 (Quality of Life Core Questionnaire of the European Organization for Research and Treatment of Cancer) as a
standardized European QOL instrument. The aim of this study was to evaluate the effect of radical procedures such as extensive
lymph node resection and combined resection of adjacent organs on patients' QOL. From 1992 to 1996, 152 patients underwent
total gastrectomy. All patients alive on July 1, 1996 were included in the study (77/152). For assessing QOL, the EORTC QOL
questionnaire QLQ-C30 version 2.0 and a validated gastric cancer module were sent home to the patients for self-completion.
The response rate was 91%. It was possible to evaluate the questionnaires of 62 patients who had undergone resection with
curative intent including 13 extended gastrectomies (21%). Of the 62 resections, 50 were combined with D2 lymphadenectomy
(80.6%). The global health status was not negatively influenced by D2 lymphadenectomy and extended gastrectomy. Patients with
splenectomy were more affected by treatment than patients without splenectomy. Radical gastrectomy combined with D2 lymphadenectomy
is the treatment of choice for gastric cancer patients, concerning not just survival but QOL as well. 相似文献
65.
AIMS:To compare nutritional counseling with and without oral supplements in HIV-infected patients with recent weight loss. DESIGN: Randomized non-blinded controlled trial, stratified for change in antiretroviral treatment at baseline. PATIENTS: HIV-infected patients with recent weight loss (> 5% of total, and >3% in the last month). INTERVENTION: Nutritional counseling to increase dietary intake by 600 kcal/day over 8 weeks; in group A (n=24) by normal food, and in group B (n=26) by a range of fortified drink supplements with a calorific value of 0.6 to 1.5 kcal/ml. METHODS: Body composition by bioelectrical impedance analysis, dietary intake by 24 h recall. RESULTS: Fat free mass increased from baseline to week 8 (P<0.05) with no difference between groups A and B (P=0.97). Body cell mass and weight gain were not significant and equal between groups. Assessed at weeks 2 and 4, group B patients consumed 11 +/- 6 kcal/kg as supplements, and their total energy intake was 6 kcal/kg higher than in group A (P<0.01). Total energy intake was not different between groups at weeks 6 and 8. DISCUSSION: Nutritional counseling and oral supplements are both feasible methods to restore food energy intake in malnourished HIV-infected patients. Although normal food intake is partially replaced, oral supplements may improve the adherence to a weight gain regimen. 相似文献
66.
H. Nier M. Wienbeck B. Ulrich K. Kremer W. Berges 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》1980,352(1):525-526
Zusammenfassung 60 gastrektomierte Patienten mit 5 Verfahren des Magenersatzes wurden nachuntersucht. Beschwerden durch einen jejuno-oesophagealen Reflux werden nur von
der Patienten mit einer Jejunuminterposition geklagt. Bei der Jejunoplicatio und der Interposition findet sich endoskopisch-histologisch die Oesophagitis qualitativ und quantitativ geringer ausgeprägt. Manometrisch kann nur bei 5 von 16 Gastrektomierten ein funktionstüchtiger unterer Oesophagussphincter nachgewiesen werden. Der Sphincterverlust muß als Mitursache des Refluxes angesehen werden. 相似文献
67.
Kremer BK 《Evaluation & the health professions》1991,14(2):187-200
Physician recertification poses a unique challenge to member boards of the American Board of Medical Specialties (ABMS) charged with the responsibility of credentialing physicians. The key issue that emerges in recertification programs is how to evaluate performance in practice. Although some test of knowledge may be appropriate, an evaluation of clinical performance has become essential in recertification programs. To meet this challenge, ABMS boards have adopted methods to evaluate performance in practice. However, regardless of the methods chosen, criteria are needed to serve as standards. This article considers the application of outcomes assessment in the definition of standards for recertification. When direct outcome assessment may not be possible, outcome-validated process measures may provide a suitable alternative. 相似文献
68.
69.
Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). 总被引:2,自引:0,他引:2
Ute Moog Eric E J Smeets Kees E P van Roozendaal Sam Schoenmakers Jos Herbergs Anneke M J Schoonbrood-Lenssen Connie T R M Schrander-Stumpel 《European journal of paediatric neurology》2003,7(1):5-12
Mutations in the MECP2 (methyl-CpG-binding protein 2) gene are known to cause Rett syndrome, a well-known and clinically defined neurodevelopmental disorder. Rett syndrome occurs almost exclusively in females and for a long time was thought to be an X-linked dominant condition lethal in hemizygous males. Since the discovery of the MECP2 gene as the cause of Rett syndrome in 1999, MECP2 mutations have, however, also been reported in males. These males phenotypically have classical Rett syndrome when the mutation arises as somatic mosaicism or when they have an extra X chromosome. In all other cases, males with MECP2 mutations show diverse phenotypes different from classical Rett syndrome. The spectrum ranges from severe congenital encephalopathy, mental retardation with various neurological symptoms, occasionally in association with psychiatric illness, to mild mental retardation only. We present a 21-year-old male with severe mental retardation, spastic tetraplegia, dystonia, apraxia and neurogenic scoliosis. A history of early hypotonia evolving into severe spasticity, slowing of head growth, breathing irregularities and good visual interactive behaviour were highly suggestive of Rett syndrome. He has a de novo missense mutation in exon 3 of the MECP2 gene (P225L). The clinical spectrum and molecular findings in males with MECP2 mutations are reviewed. 相似文献
70.
Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit. 总被引:5,自引:0,他引:5
Hans Herbert Steiner Matteo Mario Bonsanto Philipp Beckhove Michael Brysch Karsten Geletneky Rezvan Ahmadi Rebecca Schuele-Freyer Paul Kremer Golamreza Ranaie Dejana Matejic Harald Bauer Marika Kiessling Stefan Kunze Volker Schirrmacher Christel Herold-Mende 《Journal of clinical oncology》2004,22(21):4272-4281
PURPOSE: Prognosis of patients with glioblastoma is poor. Therefore, in glioblastoma patients, we analyzed whether antitumor vaccination with a virus-modified autologous tumor cell vaccine is feasible and safe. Also, we determined the influence on progression-free survival and overall survival and on vaccination-induced antitumor reactivity. PATIENTS AND METHODS: In a nonrandomized study, 23 patients were vaccinated and compared with nonvaccinated controls (n = 87). Vaccine was prepared from patient's tumor cell cultures by infection of the cells with Newcastle Disease Virus, followed by gamma-irradiation, and applied up to eight times. Antitumor immune reactivity was determined in skin, blood, and relapsed tumor by delayed-type hypersensitivity skin reaction, ELISPOT assay, and immunohistochemistry, respectively. RESULTS: Establishment of tumor cell cultures was successful in approximately 90% of patients. After vaccination, we observed no severe side effects. The median progression-free survival of vaccinated patients was 40 weeks (v 26 weeks in controls; log-rank test, P = .024), and the median overall survival of vaccinated patients was 100 weeks (v 49 weeks in controls; log-rank test, P < .001). Forty-five percent of the controls survived 1 year, 11% survived 2 years, and there were no long-term survivors (> or = 3 years). Ninety-one percent of vaccinated patients survived 1 year, 39% survived 2 years, and 4% were long-term survivors. In the vaccinated group, immune monitoring revealed significant increases of delayed-type hypersensitivity reactivity, numbers of tumor-reactive memory T cells, and numbers of CD8(+) tumor-infiltrating T-lymphocytes in secondary tumors. CONCLUSION: Postoperative vaccination with virus-modified autologous tumor cells seems to be feasible and safe and to improve the prognosis of patients with glioblastomas. This could be substantiated by the observed antitumor immune response. 相似文献